Delivery Order SPE2DB25D3202-SPE2DB25FSZUB

Award Date 3/13/25
Potential Completion Date 3/14/25
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,820.56 firm fixed-price delivery order is for the supply of 4,567,571,502 units of 30 mg lisdexamfetamine capsules. The contract has a period of performance through March 14, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,039.00 firm fixed-price delivery order is for the supply of 4,566,554,642 units of 60 mg lisdexamfetamine capsules in 100-count bottles. The contract has an ultimate completion date of November 27, 2024 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,355.83 firm fixed-price delivery order is for the supply of 4,567,074,436 units of the medication lisdexamfetamine 40 mg capsule. The contract has an ultimate completion date of January 29, 2025 and was awarded on January 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of lisdexamfetamine 30 mg capsules. The $1,345.44 firm fixed price contract has a completion date of February 10, 2025. It was awarded on February 7, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,587.26 firm fixed-price delivery order contract is for the supply of 100-count lisdexamfetamine 50 mg capsules. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,981.05 firm fixed-price delivery order is for the supply of 4,567,525,073 units of the drug Lisdexamfetamine 20 mg capsules. The contract has an ultimate completion date of March 11, 2025 and was awarded on March 10, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,426.88, is for the delivery of 4,567,422,819 units of 40 mg lisdexamfetamine capsules. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 3, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,516.41 firm fixed-price delivery order is for the supply of 4,567,299,205 units of the pharmaceutical drug lisdexamfetamine 20 mg capsules. The contract has an ultimate completion date of February 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,159.34 firm fixed-price delivery order is for the supply of 4,567,411,028 units of the prescription drug lisdexamfetamine 10 mg capsules. The contract has an ultimate completion date of February 28, 2025 and is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,288.12 firm-fixed-price delivery order is for the supply of 4,566,988,440 units of the medication Lisdexamfetamine 40 mg capsules. The award has an ultimate completion date of January 21, 2025 and is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
  • SPE2DB25D3202
    Indefinite Delivery Contract
  • SPE2DB25D3202-SPE2DB25FSZUB
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,985.51 firm fixed-price delivery order is for the supply of 100-count bottles of 30mg lisdexamfetamine capsules. The contract has an ultimate completion date of March 14, 2025.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 6/12/25, 9:49 AM